Food and Drug Administration
Antiviral Drugs Advisory Committee
August 7, 2002
Slides
Clinical Trial Design Issues for Drugs to Treat CHB htm ppt
Hepatitis B, Dr. Jay Hoofnagle, MD, NIH htm ppt
Clinical Trial Design - Hepatitis B Treatment, Dr. Anna Lok, MD, U. of Michigan htm ppt
Pharmaceutic Devepment Issues for Hepatitis B, Dr. Nathaniel Brown, MD, Idenix Pharmaceuticals htm ppt
Surrogate Endpoints for Hepatitis B Trials, Dr. Greg Soon, PhD and Dr. Rafia Bhore, PhD, FDA htm ppt